TransMedics Group, Inc.
TMDX
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditā¦ read more
Healthcare
Medical Devices
6 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$123.48
Price+1.79%
$2.17
1Y
Price
Market Cap
$4.236b
Mid
Price/Earnings 3y Avg5y Avg
25.4x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+20.2%
EBITDA Margin+65.6%
Net Profit Margin+11.8%
Free Cash Flow Margin+20.2%
EBITDA Margin+65.6%
Net Profit Margin+11.8%
Free Cash Flow MarginRevenue
$605.494m
+37.1%
1y CAGR+92.8%
3y CAGR+121.8%
5y CAGREarnings
$190.291m
+436.6%
1y CAGR+236.4%
3y CAGR+181.8%
5y CAGREPS
$4.87
+382.2%
1y CAGR+216.9%
3y CAGR+168.5%
5y CAGRBook Value
$473.100m
$1.068b
Assets$595.273m
Liabilities$469.691m
DebtDebt to Assets
44.0%
3.2x
Debt to EBITDAFree Cash Flow
$133.589m
+265.0%
1y CAGR+30.0%
3y CAGR+3.0%
5y CAGRNo items found.
Press Releases
Statements and updates from the company